Sfoglia per Rivista  

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Mostrati risultati da 52 a 71 di 79
Titolo Data di pubblicazione Autore(i) File
Induction of nitric oxide synthase is involved in the mechanism of Fas-mediated apoptosis in CD34+ cells. 1-gen-1998 Selleri, Carmine; Jp, Maciejewski; T., Sato; A., Raiola; Am, Risitano; L., Pezzullo; B., Rotoli
INTENSIFICATION AND MAINTENANCE WITH RITUXIMAB IN PATIENTS WITH DLBCL IN UNCERTAIN CR OR PR (PET-ORIENTED) AFTER INDUCTION THERAPY WITH R-CHOP OR SIMILAR THERAPIES; OUR EXPERIENCE 1-gen-2021 Pezzullo, L; D'Addona, M; Ferrara, I; Luponio, S; Giudice, V; Fontana, R; Serio, B; Mettivier, L; Martorelli, C; Guariglia, R; Selleri, C
Mixed backbone antisense oligonucleotide targeting protein kinase A may induce growth inhibition of human primary chronic lymphocytic leukemia cells in vitro. 1-gen-1999 Selleri, Carmine; Mr, Villa; R., Caputo; F., Chiurazzi; P., Ricci; G., Tortora; B., Rotoli
Multiple molecular mechanism may account for resistance to imatinib in resistant cell lines 1-gen-2007 N., Esposito; B., Izzo; F., Quarantelli; I., Colavita; T., Buonomo; V., Roberti; S., Soverini; J. V., Melo; G., Martinelli; Martinelli, Rosanna; M., Ruoppolo; B., Rotoli; F., Pane
Post-transplant cerebral toxoplasmosis diagnosed by magnetic resonance imaging. 1-gen-1998 M., Picardi; G. D., Rosa; DI SALLE, Francesco; L., Pezzullo; A., Raiola; B., Rotoli
Previous occurrence of life-threatening abdominal infection is not a contraindication to bone marrow transplantation. 1-gen-1999 Picardi, M; Selleri, Carmine; De Rosa, G; Califano, C; Camera, A; Rotoli, B.
Prolonged azacitidine treatment in the management of elderly patients with high risk myelodysplastic syndromes, chronic myelomonocytic leukemia and acute myeloid leukemia not eligible for standard intensive therapy 1-gen-2013 Serio, B; Pezzullo, L; Fontana, R; Annunziata, S; Rosamilio, R; Rocco, M; Villani, G; Giudice, V; Sessa, M; Russo, R; Baldi, C; Ferrara, I; Selleri, Carmine
Prolonged low-dose lenalidomide treatment increases the number of circulating natural killer cells in multiple mieloma patients 1-gen-2013 Rocco, M; Villani, G; Sessa, M; Rosamilio, R; Giudice, V; Pezzullo, L; Fontana, R; Serio, B; Annunziata, S; Ferrara, I; Selleri, Carmine
Prolonged response to cyclosporin-A in hypoplastic refractory anemia and correlation with in vitro studies. 1-gen-2000 Catalano, L; Selleri, Carmine; Califano, C; Luciano, L; Volpicelli, M; Rocco, S; Varriale, G; Ricci, P; Rotoli, B.
Prophylactic therapy with oral low-dose valgancyclovir in cytomegalovirus-positive allogeneic stem cell transplant recipients 1-gen-2013 Serio, B; Pezzullo, L; Fontana, R; Annunziata, S; Rosamilio, R; Ferrara, I; Rocco, M; Giudice, V; Sessa, M; Montuori, N; Selleri, Carmine
Pure granuloblastic aplasia 1-gen-1999 S., Rocco; L., Catalano; Selleri, Carmine; P. Ricci A., Severino; Am, Risitano; Ml, Barone; M., Volpicelli; M., Rossi; Mr, Villa; A., Camera; B., Rotoli
REDUCED LEVELS OF SHP1 PROVIDES AN ADDITIVE SURVIVAL ADVANTAGE TO THE PH(+) CELLS OF CML PATIENTS AND MAY ACCOUNT FOR RESISTANCE TO IMA TREATMENT 1-gen-2008 N., Esposito; I., Colavita; B., Izzo; F., Quarantelli; R. A., Sica; T., Buonomo; V., Roberti; L., Luciano; L. D., Vecchio; A., Peluso; J. V., Melo; D., Russo; G., Martinelli; Martinelli, Rosanna; M., Ruoppolo; F., Pane
SERUM FREE LIGHT CHAIN RATIO AS A BIOMARKER OF MULTIPLE MYELOMA PROGRESSION AND ASSOCIATED RENAL DISEASE 1-gen-2022 De Novellis, D; Carobene, A; Fontana, R; Serio, B; Ferrara, I; Martorelli, M; Guariglia, R; Luponio, S; Ruggiero, I; Giudice, V; Selleri, C
Seven novel mutations of the UGT1A1 gene in patients with unconjugated hyperbilirubinemia 1-gen-2007 D'Apolito, M; Marrone, A; Servedio, V; Vajro, Pietro; DE FALCO, L; Iolascon, A.
A simple flow cytometric score based on CD49d and homing marker expression in chronic lymphocytic leukemia (CLL). 1-gen-2017 Giudice, V; Rinaldi, A; Ferrara, I; Martorelli, Mc; Pezzullo, L; Fontana, R; Langella, M; Guariglia, R; Serio, B; Rocco, M; Villani, G; Selleri, C.
Sirt-1 as a novel therapeutic target for improving nitric oxide release in heterozygous and homozygous patients for mthfr mutations 1-gen-2013 Rocco, M; Carrizzo, A; Annunziata, S; Sessa, M; Giudice, V; Rosamilio, R; Serio, B; Trimarco, V; Damato, A; Vecchione, C; Selleri, Carmine
Soluble forms of UPAR regulate adhesion, proliferation and survival of KG1 leukemic cells 1-gen-2013 Selleri, Carmine; N., Montuori; M., Rocco; B., Serio; A., Salvati; Lisanti, A.; A., Gorrasi; Ragno, Pia
Spleen enlargement following recombinant human granulocyte colony-stimulating factor administration for peripheral blood stem cell mobilization. 1-gen-2003 Picardi, M; De Rosa, G; Selleri, Carmine; Scarpato, N; Soscia, E; Martinelli, V; Ciancia, R; Rotoli, B.
Steroid treatment of acute graft-versus-host disease grade I: A randomized trial 1-gen-2017 Bacigalupo, A; Milone, G; Cupri, A; Severino, A; Fagioli, F; Berger, M; Santarone, S; Chiusolo, P; Sica, S; Mammoliti, S; Sorasio, R; Massi, D; Van Lint, Mt; Raiola, Am; Gualandi, F; Selleri, C; Sormani, Mp; Signori, A; Risitano, A; Bonifazi, F
Subcutaneous low-dose IL-2 for remission maintenance in elderly acute myeloid leukemia patients. 1-gen-1996 R., Notaro; Selleri, Carmine; G., Caparrotti; M., Picardi; di Grazia, C; D., Pagnini; N., Cantore; A., Andriani; Carella, M; L., Catalano; L., Del Vecchio; R., Di Girolamo; E., Volpe; M., Carotenuto; B., Rotoli
Mostrati risultati da 52 a 71 di 79
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile